New NASH (Fatty Liver) Clinical Trials

The Effect of a Probiotic on Hepatic Steatosis

Non-alcoholic fatty liver disease (NAFLD) is an accumulation of fat and fibrous tissue in the liver. It is the most common cause of chronic liver disease in the United States. The exact cause of NAFLD is unknown, but it is more common among people with conditions such as [...]

New Hepatitis B Clinical Trials

Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-Resistant Chronic Hepatitis BAntiviral resistance mutations limit the efficacy of therapy for chronic hepatitis B. At year 2, resistance to adefovir may occur as high as 25% in patients with history of lamivudine resistance. Resistance to entecavir is reported to be 10% in lamivudine refractory [...]

New Hepatitis C Clinical Trials

Nowaday hepatitis C response to the treatment is between 50 and 80 % . Here I choose a list of new trials to inprove the response and the qol of patients with HEP C.
Vaccine :
Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is [...]

Lasker Awards Winners Announced

NEW YORK (AP) — Two researchers who opened up the field of heart-valve replacement and a scientist who discovered a type of cell that plays a key role in the immune system have won prestigious medical prizes.
The $150,000 Albert Lasker Medical Research Awards will be presented Sept. 28 in New York by the Albert [...]

La mejor enseñanza acerca de lo que es la Anorexia y la Bulimia (Video)

Hospital Ranking